Evidence map›Paper›PMID 38413241›Full record

ArticleEmerging infectious diseases2024

Chlamydia pneumoniae Upsurge at Tertiary Hospital, Lausanne, Switzerland.

Florian Tagini, Onya Opota, Gilbert Greub

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Upsurge of Chlamydia pneumoniae respiratory tract infections in 2024/2025 in Southern Germany.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Frontiers in cellular and infection microbiology · 2026
    Review
  5. Article
  6. Characteristics ofFrontiers in pediatrics · 2026
    Article
  7. Article
  8. Clinical features and chest CT findings ofFrontiers in medicine · 2026
    Article
  9. Surge inEmerging microbes & infections · 2025
    Article
  10. Article
  11. Sharp increase in Chlamydia pneumoniae infections in 2024 in Germany.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  12. Article
  13. Epidemiological changes inEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  14. From coughs to complications: the story ofJournal of medical microbiology · 2025
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Florian Tagini
Onya Opota
Gilbert Greub

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydia pneumoniae infection cases have usually accounted for <1.5% of community-acquired respiratory tract infections. Currently, Lausanne, Switzerland is experiencing a notable upsurge in cases, with 28 reported within a span of a few months. This upsurge in cases highlights the need for heightened awareness among clinicians.

Indexed as

Chlamydia InfectionsChlamydophila pneumoniaeCommunity-Acquired InfectionsRespiratory Tract InfectionsHumansSwitzerlandTertiary Care CentersasthmabacteriaChlamydia pneumoniaecommunity-acquired pneumoniaintracellular bacteriaoutbreakpneumoniarespiratory infectionsSwitzerland

Identifiers

PMID38413241
PMCPMC10977832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.